Durysta™ (bimatoprost implant) – New drug approval
March 5, 2020 - Allergan announced the FDA approval of Durysta (bimatoprost implant), for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT).
Download PDF
